Articles

A study focused on social networking and support groups showed the effects of these programs on blood sugar levels are short-term….

Study shows type 1 diabetes patients do not need to adjust their flexible insulin scale based on the amount of protein they are about to consume….

More active type 1 diabetes patients are at a greater risk for hypoglycemia and therefore may consume an increased amount of carbohydrates….

Awareness of prediabetes is low, less than 14% of people in the U.S. are aware of the condition….

Intradermal insulin injection via a microneedle provided less pain and increased kinetics….

Reduced calories before and after surgery improves diabetes in type 2 patients but not the actual surgery….

Diabetic patients on antidepressants who don’t understand basic health information are not as likely to continue taking medications….

Andre McMahon, PharmD Candidate, University of Florida College of Pharmacy Dave Joffe, Editor-in-chief, Diabetes In Control The metabolic syndrome is associated with many risk factors for type 2 diabetes mellitus and cardiovascular complications which include: central obesity, elevated fasting glucose, elevated triglycerides, decreased high-density lipoprotein (HDL) cholesterol, and hypertension. When a …

Johnson & Johnson’s SGLT2 canagliflozin (Invokana) has just received FDA approval, while Boehringer Ingelheim and Eli Lilly submit their SGLT2 inhibitor (empagliflozin) to the FDA…. U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. …

A community-based diabetes-prevention program produced significant reductions in blood glucose and body mass index (BMI) among individuals with prediabetes, while also reducing costs at 2 years….